Research and Clinical Trials

Title  
Lundbeck Lu AF35700
Brief Description  
LuAF35700 is an investigational antipsychotic medication which is being studied as a treatment for patients with schizophrenia who, despite being treated with one or more approved antipsychotic drugs, have not experienced a significant relief of their symptoms.
Who may be Eligible  
Male or female 18 years or older.
Specialty/Disorder  
Schizophrenia
Start Date  
06/01/2016
IRB Number  
06-16-07B
Principal Investigator  
Tcheremissine, Oleg
Contact Name  
Dineen

For More Information, Contact   Dineen  Gardner , BA
Phone:  (704) 446-7511  Fax:  (704) 446-7505 
Email:  Dineen.Gardner@carolinashealthcare.org
Address:  465 North Wendover Road
Charlotte, NC
Close